Low Grade Lymphoma
NCT01698866
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Indolent Lymphoproliferative Disorders
Interventions
BIOLOGICAL:
Vaccin GenHevac B Pasteur
Sponsor
Central Hospital, Nancy, France